Article Details
Retrieved on: 2022-02-10 01:46:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Research Capital Corporation analyst Venkata Velagapudi still has a positive angle on Auxly Cannabis, maintaining a “Buy” rating and $0.45/share ...
Article found on: www.cantechletter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here